ICLR ICON PLC

Farmers & Merchants Investments Inc. reduced its stake in Icon Plc (NASDAQ:ICLR) by 8.6% in the third quarter of 2025, now holding 80,038 shares valued at approximately $14.01 million. Despite this trim, institutional investors collectively own 95.61% of Icon's stock, and several other funds initiated or increased their positions. Analysts maintain a "Moderate Buy" rating for Icon, with an average price target of $205.31, while the stock currently trades around $182.36.

Live Oak Private Wealth LLC increased its stake in Icon Plc (NASDAQ:ICLR) by 44.2% during the third quarter, purchasing an additional 5,593 shares to own a total of 18,233 shares valued at approximately $3.19 million. This move is part of broader institutional interest, with hedge funds and other institutional investors owning 95.61% of the company's stock. Icon Plc, a medical research company with a market capitalization of $14.77 billion, currently holds a "Moderate Buy" consensus rating from analysts with an average target price of $205.31.

Rice Hall James & Associates LLC significantly increased its stake in Icon Plc, acquiring an additional 9,889 shares to a total of 12,163 shares worth approximately $2.13 million. Institutional investors collectively own 95.61% of Icon's stock, with several other hedge funds also adjusting their holdings. Icon Plc (NASDAQ:ICLR) holds a "Moderate Buy" consensus rating from analysts, with an average price target of $205.31.

Swedbank AB has increased its stake in Icon Plc (NASDAQ:ICLR) by 15.1%, purchasing an additional 6,300 shares to own a total of 48,100 shares valued at $8.418 million. Institutional ownership of Icon Plc is high at 95.61%, with several other funds also adding to or initiating positions in Q3. Analyst sentiment for Icon Plc is moderately positive, holding an average "Moderate Buy" rating with a consensus price target of $205.31.

Coho Partners Ltd. significantly reduced its stake in Icon Plc by 34.1% in Q3 2025, selling 78,840 shares, yet Icon still represents 3.4% of Coho's portfolio with a value of $26.69 million. Meanwhile, other major institutions like Artisan Partners and MFS increased their holdings, leading to institutional ownership of approximately 95.61% of Icon's stock. Analyst ratings are mixed but lean towards a "Moderate Buy" consensus with an average target price of $205.31.

LVM Capital Management Ltd. MI reduced its stake in Icon Plc (NASDAQ:ICLR) by 18.8% in the third quarter, selling 7,614 shares and ending with holdings valued at $5.77 million. Icon is highly institutionally owned, and analysts currently rate the stock as a "Moderate Buy" with a consensus target price of $205.31. The medical research company opened at $173.77, has a market cap of $14.03 billion, and a P/E ratio of 23.51.